Cord Blood America has acquired $200,000 in capital from a leading institutional investment firm in New York City. The funds will be used to complete a potential acquisition mentioned in a Letter of Intent.
The CEO of Cord Blood America stated that the debt placement minimizes dilution and protects their shareholders. He comments, “It’s easier to make acquisitions when you have the financing already secured.” Any company experiencing growth will require funds. The liability is expected to be promptly paid with cash flow from the anticipated acquisition.
Let us hear your thoughts below:
